Cannabis Bioscience International Holdings, Inc. reported earnings results for the second quarter and six months ended November 30, 2023. For the second quarter, the company reported sales was USD 0.063748 million compared to USD 0.082581 million a year ago. Net loss was USD 0.124428 million compared to USD 0.219886 million a year ago. Basic loss per share from continuing operations was USD 0.00002 compared to USD 0.00004 a year ago.
For the six months, sales was USD 0.136569 million compared to USD 0.219162 million a year ago. Net loss was USD 0.306217 million compared to USD 0.431917 million a year ago. Basic loss per share from continuing operations was USD 0.00003 compared to USD 0.00005 a year ago.